AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
NVIDIA
NVDA
|
+$402M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$287M |
| 4 |
Automatic Data Processing
ADP
|
+$276M |
| 5 |
Honeywell
HON
|
+$270M |
Top Sells
| 1 |
Booking.com
BKNG
|
+$422M |
| 2 |
Apple
AAPL
|
+$354M |
| 3 |
Gilead Sciences
GILD
|
+$352M |
| 4 |
RTX Corp
RTX
|
+$292M |
| 5 |
Ecolab
ECL
|
+$222M |
Sector Composition
| 1 | Technology | 21.63% |
| 2 | Healthcare | 17.29% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 11.04% |
| 5 | Communication Services | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Core Laboratories
CLB
$577M
| $520K | ﹤0.01% |
50,291
-1,580
| -3% | -$16.3K |
|
2327
Oceaneering
OII
$2.45B
| $520K | ﹤0.01% |
176,847
+21,999
| +14% | +$64.7K |
|
2328
Alaunos Therapeutics
TCRT
$4.83M
| $518K | ﹤0.01% |
1,410
-68
| -5% | -$25K |
|
2329
AnaptysBio
ANAB
$637M
| $516K | ﹤0.01% |
36,486
-73,644
| -67% | -$1.04M |
|
2330
Smith & Wesson
SWBI
$416M
| $516K | ﹤0.01% |
80,838
+18,084
| +29% | +$115K |
|
2331
Pitney Bowes
PBI
$1.96B
| $514K | ﹤0.01% |
252,200
-25,300
| -9% | -$51.6K |
|
|
OXFD
2332
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $514K | ﹤0.01% |
55,500
-11,000
| -17% | -$102K |
|
|
AC
2333
DELISTED
Associated Capital Group
AC
| $513K | ﹤0.01% |
16,837
-402
| -2% | -$12.2K |
|
2334
Nicolet Bankshares
NIC
$2B
| $513K | ﹤0.01% |
9,400
+700
| +8% | +$38.2K |
|
|
NVEE
2335
DELISTED
NV5 Global
NVEE
| $512K | ﹤0.01% |
49,600
+16,800
| +51% | +$173K |
|
2336
Minerva Neurosciences
NERV
$15M
| $506K | ﹤0.01% |
10,513
| – | – |
|
|
VBFC
2337
DELISTED
Village Bank and Trust Financial Corp.
VBFC
| $506K | ﹤0.01% |
19,988
+3,294
| +20% | +$83.4K |
|
|
TGH
2338
DELISTED
Textainer Group Holdings limited
TGH
| $506K | ﹤0.01% |
61,500
+38,300
| +165% | +$315K |
|
2339
Agilysys
AGYS
$3.03B
| $505K | ﹤0.01% |
30,227
+12,750
| +73% | +$213K |
|
2340
Q32 Bio
QTTB
$21.7M
| $505K | ﹤0.01% |
1,806
+200
| +12% | +$55.9K |
|
2341
Adtran
ADTN
$849M
| $502K | ﹤0.01% |
65,403
+50
| +0.1% | +$384 |
|
2342
Univest Financial
UVSP
$894M
| $502K | ﹤0.01% |
30,754
| – | – |
|
2343
Clearwater Paper
CLW
$342M
| $501K | ﹤0.01% |
22,966
+3,950
| +21% | +$86.2K |
|
2344
CryoPort
CYRX
$480M
| $500K | ﹤0.01% |
29,300
| – | – |
|
2345
G-III Apparel Group
GIII
$1.13B
| $497K | ﹤0.01% |
64,568
-65,931
| -51% | -$507K |
|
2346
SunCoke Energy
SXC
$656M
| $496K | ﹤0.01% |
128,956
+32,550
| +34% | +$125K |
|
|
CNSL
2347
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $496K | ﹤0.01% |
108,991
-9,650
| -8% | -$43.9K |
|
2348
Dorian LPG
LPG
$1.35B
| $496K | ﹤0.01% |
56,932
+6,548
| +13% | +$57K |
|
|
GTHX
2349
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $495K | ﹤0.01% |
44,900
| – | – |
|
2350
CytomX Therapeutics
CTMX
$341M
| $494K | ﹤0.01% |
64,400
+5,600
| +10% | +$43K |
|